Found 5 matching trials
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
PHASE1This is a single arm, open-label, dose escalation clinical study to evaluat...
Location
Zhongshan Hospital Affiliated to Fudan University
AFPᶜ³³²T in Advanced HCC
PHASE1This first time in human study is intended for men and women between 18 and...
Location
Mayo Clinic Arizona
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma
PHASE1A study that aimed to assess the safety and anti-tumor activity of C-TCR055...
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
PHASE1The goal of this Phase I/II observational and interventional platform study...
Location
Multiple Locations
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma
PHASE1A phase 1 study that aimed to assess the safety and anti-tumor activity of ...
Location
Fudan University Affiliated ZhongShan Hospital